In last trading session, Fresenius Medical Care AG ADR (NYSE:FMS) saw 0.38 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $28.78 trading at $0.38 or 1.34% at ring of the bell on the day assigns it a market valuation of $16.89B. That closing price of FMS’s stock is at a premium of 0.66% from its 52-week high price of $28.59 and is indicating a premium of 37.7% from its 52-week low price of $17.93. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.62 million shares which gives us an average trading volume of 412.75K if we extend that period to 3-months.
For Fresenius Medical Care AG ADR (FMS), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.68. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Fresenius Medical Care AG ADR (NYSE:FMS) trade information
Upright in the green during last session for gaining 1.34%, in the last five days FMS remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $28.78 price level, adding 0.07% to its value on the day. Fresenius Medical Care AG ADR’s shares saw a change of 27.12% in year-to-date performance and have moved 1.37% in past 5-day. Fresenius Medical Care AG ADR (NYSE:FMS) showed a performance of 16.28% in past 30-days. Number of shares sold short was 0.7 million shares which calculate 1.9 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 17.85 to the stock, which implies a fall of -61.23% to its current value. Analysts have been projecting 11.7 as a low price target for the stock while placing it at a high target of 24. It follows that stock’s current price would jump 59.35% in reaching the projected high whereas dropping to the targeted low would mean a gain of 59.35% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -14.87% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 27.53% while estimates for its earnings growth in next 5 years are of 16.44%.
FMS Dividends
Fresenius Medical Care AG ADR is more likely to be releasing its next quarterly report on 2025-May-05 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 2.23%, the share has a forward dividend of 0.64 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 1.3%.
Fresenius Medical Care AG ADR (NYSE:FMS)’s Major holders
Investors also watch the number of corporate investors in a company very closely, which is 7.69% institutions for Fresenius Medical Care AG ADR that are currently holding shares of the company. PZENA INVESTMENT MANAGEMENT LLC is the top institutional holder at FMS for having 16.18 million shares of worth $308.96 million. And as of 2024-06-30, it was holding 5.5158 of the company’s outstanding shares.
The second largest institutional holder is FIDUCIARY MANAGEMENT INC /WI/, which was holding about 5.17 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.762 of outstanding shares, having a total worth of $98.69 million.
On the other hand, VANGUARD WINDSOR FUNDS-Vanguard Windsor Fund and Dodge & Cox Funds-Dodge & Cox Balanced Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 8.2 shares of worth $236.13 million or 1.40% of the total outstanding shares. The later fund manager was in possession of 4.17 shares on Dec 31, 2024 , making its stake of worth around $120.11 million in the company or a holder of 0.71% of company’s stock.
